SR-80258A

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameSR-80258A
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionThrombin inhibitors
TargetsProthrombin
Therapy Area/IndicationsThrombosisMyocardial Ischemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi-Synthelabo
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi-Synthelabo
Active IndicationsN/A
Inactive IndicationsThrombosisMyocardial Ischemia

Other Information

ATC CodeN/A
Related LinksN/A